Rezera Inc. plans to list on the Nasdaq under the symbol RZRA. It filed a Form S-1 registration statement for an initial public offering on October 21, 2026. As of November 4, 2026, its registration is on file (Form S-1, October 21, 2026).
Sell to companies like Rezera Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Rezera Inc. filed a Form S-1 registration statement for an initial public offering on 2026-10-21. As of its latest filing, on 2026-10-21, it has not priced the offering or withdrawn it. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We intend to apply to list our common stock on the Nasdaq Market under the symbol “RZRA.” We believe that upon the completion of this offering, we will meet the standards for listing on the Nasdaq Market, and the completion of this offering is contingent upon such listing.From the S-1 filed 2026-10-21
Use of proceeds
We currently intend to use the net proceeds from this offering, together with our existing cash and cash equivalents, to advance ruvonoflast through our proposed Phase 3 clinical trial in PAD, invest in commercial readiness for ruvonoflast, if approved, and fund continued development for our earlier stage pipeline; and the remainder for working capital and general corporate purposes.From the S-1 filed 2026-10-21
Net loss or income
For the years ended December 31, 2025 and 2024, we reported net losses of $42.2 million and $25.2 million, respectively.From the S-1 filed 2026-10-21
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2026-10-21 | Registration statement filed | S-1 |
Check before you invest in Rezera Inc.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on Rezera Inc. and the records around it.
Also filing to list on the Nasdaq
IPO filings on the Nasdaq in Q4 2026, newest first.
- Parabolic Technologies, Inc. (Oct 2026)
- DataMeds AI, Inc. (Oct 2026)
Watch Rezera Inc.
Get an email when Rezera Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Rezera Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Rezera Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Rezera Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for Rezera Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.